MBX Biosciences

MBX Biosciences

Advancing potential breakthrough medicines for endocrine diseases of substantial medical need.

Launch date
Employees
Market cap
CAD922m
Enterprise valuation
CAD847m (Public information from Sep 2024)
Carmel Indiana (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD20222023
EBITDA(24.7m)(32.4m)
Profit(26.1m)(32.6m)
R&D budget21.4m28.5m
  • Edit

Recent News about MBX Biosciences

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.